Key result
Inhibition of the TRPM4 channel with 9-phenanthrol or shRNA decreased mineralization and osteogenic markers in human valvular interstitial cells cultured in pro-calcifying media.
Why the study?
Aortic stenosis currently has no non-surgical correction due to poor knowledge of cellular mechanisms, prompting investigation into whether the TRPM4 channel contributes to human valvular interstitial cell transition to an osteoblastic phenotype.
Does TRPM4 inhibition prevent osteogenic differentiation in human aortic valve interstitial cells?
Does TRPM4 inhibition prevent osteogenic differentiation in human aortic valve interstitial cells?
Inhibition of the TRPM4 channel reduces osteogenic differentiation of human aortic valve interstitial cells, highlighting a potential target to prevent aortic valve calcification.
Answers are grounded in this paper and cite their sources.
TRPM4 inhibition may limit valvular calcification; hypothesis-generating for targeted therapies pending in vivo validation.
BACKGROUND: Aortic stenosis due to deleterious remodeling of the aortic valve is a health concern since it can be corrected only by valve replacement due to the poor knowledge of cellular mechanisms involved. Fibroblastic valvular interstitial cells (VICs) play a central role in valve leaflet stiffness by trans-differentiation into osteoblast-like cells leading to calcification. The TRPM4 (transient receptor potential melastatin 4) cation channel was shown to participate in cardiac fibroblast remodeling. It is also involved in radiation-induced aortic valve remodeling in vivo in mice. We hypothesized that TRPM4 might participate in human VIC transition to osteoblastic phenotype. METHODS: Human aortic valves were collected from patients undergoing surgical valve replacement. Isolated VICs were maintained 14 days in culture in standard or pro-calcifying media and submitted to the TRPM4 inhibitor 9-phenanthrol, or small hairpin RNA-TRPM4. Osteogenic differentiation was evaluated by measuring hydroxyapatite crystals by Alizarin red staining and protein expression of osteogenic markers. VICs maintained in pro-calcifying media exhibited a higher mineralization than in standard media, with an increase in osteogenic markers. Mineralization and osteogenic markers (bone morphogenetic protein 2, runt-related transcription factor 2) were decreased when pro-calcifying media contained 9-phenanthrol or small hairpin RNA-TRPM4. Similarly, SMAD1/5 and nuclear factor of activated T-cell pathways were stimulated in pro-calcifying media conditions compared with standard media but reduced by 9-phenanthrol or small hairpin RNA-TRPM4. CONCLUSIONS: TRPM4 participates in osteogenic differentiation of human VICs and thus appears as a target to prevent aortic valve remodeling.
No takes yet. Share an insight, caveat, or question.
Aize et al. (2025) studied Aortic stenosis. TRPM4 inhibition (9-phenanthrol or small hairpin RNA-TRPM4) vs. Pro-calcifying media without TRPM4 inhibition was evaluated on Osteogenic differentiation (mineralization and osteogenic markers). Inhibition of the TRPM4 channel with 9-phenanthrol or shRNA decreased mineralization and osteogenic markers in human valvular interstitial cells cultured in pro-calcifying media.
Synapse has enriched 10 related papers. Consider them for comparative context: